The UK Health Security Agency (UKHSA) announced on Friday that the country had identified the first case of the COVID-19 variant BA.2.86 in an individual who had not traveled recently.
Similarly, the U.S. Centers for Disease Control and Prevention stated on Thursday that they were monitoring this new, extensively mutated virus variant responsible for COVID. This variant has also been detected in Israel, Denmark, and the United States.
The identification of this variant has heightened concerns about a potential resurgence of Covid cases in the UK.
Over the past month, there has been an increase in hospital admissions for the virus, which aligns with the waning effectiveness of vaccines and the emergence of a new variant.
Meanwhile, government officials have chosen not to provide Covid boosters to nearly 12 million British individuals during the upcoming winter. The Joint Committee on Vaccination and Immunisation has recommended that most healthy adults under 65 will not qualify for a booster, a recommendation that the government has approved.
In the previous autumn, vaccination invitations were extended to all individuals aged 50 and above, but the criteria for eligibility have been more restricted this year.
Based on official data, by the end of last Saturday, there had been an additional 930 Covid cases in England in comparison to the preceding week.
Dr Meera Chand, deputy director of UKHSA, said: “We’re aware that BA.2.86 has been detected in the UK. UKHSA is assessing the situation and will provide further information in due course.”
Earlier this week, scientists from the Independent Sage group warned it was “reasonably certain” the UK was already in another wave of Covid-19 – and suggested people should wear face masks again.
Up until now, Denmark and Israel have identified three instances of the recently identified BA.X strain, also referred to as BA.2.86. Subsequently, a fourth case was discovered in Michigan, USA.
Distinguished by over 30 mutations on its spike protein, the strain surpasses other prevalent variants in terms of mutation count. This development is believed to be the reason for the swift elevation of concern by the World Health Organization (WHO).
